These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 22332189

  • 1. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.
    Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ.
    Arch Neurol; 2012 Feb; 69(2):223-9. PubMed ID: 22332189
    [Abstract] [Full Text] [Related]

  • 2. Association of lifetime cognitive engagement and low β-amyloid deposition.
    Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust WJ.
    Arch Neurol; 2012 May; 69(5):623-29. PubMed ID: 22271235
    [Abstract] [Full Text] [Related]

  • 3. β-Amyloid affects frontal and posterior brain networks in normal aging.
    Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ.
    Neuroimage; 2011 Feb 01; 54(3):1887-95. PubMed ID: 20965254
    [Abstract] [Full Text] [Related]

  • 4. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.
    Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust WJ.
    Alzheimers Dement; 2013 Nov 01; 9(6):687-698.e1. PubMed ID: 23474040
    [Abstract] [Full Text] [Related]

  • 5. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
    Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Kosaka J, Kudo T, Iida H, Kishimoto T, Nagatsuka K.
    Int J Geriatr Psychiatry; 2016 Aug 01; 31(8):920-8. PubMed ID: 26766490
    [Abstract] [Full Text] [Related]

  • 6. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC.
    JAMA Neurol; 2013 Jul 01; 70(7):903-11. PubMed ID: 23712469
    [Abstract] [Full Text] [Related]

  • 7. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
    Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, DeCarli C, Weiner MW, Mungas DM, Chui HC, Jagust WJ.
    JAMA Neurol; 2013 Apr 01; 70(4):488-95. PubMed ID: 23400560
    [Abstract] [Full Text] [Related]

  • 8. Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study.
    Snitz BE, Lopez OL, McDade E, Becker JT, Cohen AD, Price JC, Mathis CA, Klunk WE.
    J Alzheimers Dis; 2015 Sep 24; 48 Suppl 1(0 1):S151-9. PubMed ID: 26402082
    [Abstract] [Full Text] [Related]

  • 9. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
    Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust WJ.
    J Neurosci; 2013 Mar 27; 33(13):5553-63. PubMed ID: 23536070
    [Abstract] [Full Text] [Related]

  • 10. Amyloid-Beta Deposition is Associated with Increased Medial Temporal Lobe Activation during Memory Encoding in the Cognitively Normal Elderly.
    Edelman K, Tudorascu D, Agudelo C, Snitz B, Karim H, Cohen A, Mathis C, Price J, Weissfeld L, Klunk W, Aizenstein H.
    Am J Geriatr Psychiatry; 2017 May 27; 25(5):551-560. PubMed ID: 28161156
    [Abstract] [Full Text] [Related]

  • 11. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
    Nadkarni NK, Perera S, Snitz BE, Mathis CA, Price J, Williamson JD, DeKosky ST, Klunk WE, Lopez OL.
    JAMA Neurol; 2017 Jan 01; 74(1):82-90. PubMed ID: 27842173
    [Abstract] [Full Text] [Related]

  • 12. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
    Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J, Iida H, Kishimoto T, Nagatsuka K.
    Neuroimage Clin; 2017 Jan 01; 13():209-214. PubMed ID: 28003959
    [Abstract] [Full Text] [Related]

  • 13. Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition.
    Chételat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, Martins RN, Masters CL, Rowe CC, AIBL Research Group.
    Neurology; 2012 Feb 14; 78(7):477-84. PubMed ID: 22302548
    [Abstract] [Full Text] [Related]

  • 14. Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.
    Cairns NJ, Ikonomovic MD, Benzinger T, Storandt M, Fagan AM, Shah AR, Reinwald LT, Carter D, Felton A, Holtzman DM, Mintun MA, Klunk WE, Morris JC.
    Arch Neurol; 2009 Dec 14; 66(12):1557-62. PubMed ID: 20008664
    [Abstract] [Full Text] [Related]

  • 15. β-Amyloid Deposition Is Associated with Decreased Right Prefrontal Activation during Task Switching among Cognitively Normal Elderly.
    Oh H, Steffener J, Razlighi QR, Habeck C, Stern Y.
    J Neurosci; 2016 Feb 10; 36(6):1962-70. PubMed ID: 26865619
    [Abstract] [Full Text] [Related]

  • 16. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
    Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ.
    JAMA Neurol; 2013 Dec 10; 70(12):1512-9. PubMed ID: 24166579
    [Abstract] [Full Text] [Related]

  • 17. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition.
    Storandt M, Mintun MA, Head D, Morris JC.
    Arch Neurol; 2009 Dec 10; 66(12):1476-81. PubMed ID: 20008651
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal patterns of β-amyloid deposition in nondemented older adults.
    Sojkova J, Zhou Y, An Y, Kraut MA, Ferrucci L, Wong DF, Resnick SM.
    Arch Neurol; 2011 May 10; 68(5):644-9. PubMed ID: 21555640
    [Abstract] [Full Text] [Related]

  • 19. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Li Y, Rinne JO, Mosconi L, Pirraglia E, Rusinek H, DeSanti S, Kemppainen N, Någren K, Kim BC, Tsui W, de Leon MJ.
    Eur J Nucl Med Mol Imaging; 2008 Dec 10; 35(12):2169-81. PubMed ID: 18566819
    [Abstract] [Full Text] [Related]

  • 20. Imaging beta-amyloid burden in aging and dementia.
    Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL.
    Neurology; 2007 May 15; 68(20):1718-25. PubMed ID: 17502554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.